PPT-New Insights into the Roadmap of Pathogenesis of Liver Fibrosis

Author : tatiana-dople | Published Date : 2018-10-30

By Dr Eman Gamal ElDin El Ahwany Professor of Immunology Immunology Department Theodor Bilharz Research Institute 3 rd Congress of Hepatitis and Liver

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "New Insights into the Roadmap of Pathog..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

New Insights into the Roadmap of Pathogenesis of Liver Fibrosis: Transcript

By Dr Eman Gamal ElDin El Ahwany Professor of Immunology Immunology Department Theodor Bilharz Research Institute 3 rd Congress of Hepatitis and Liver Diseases October 1012 2016 Dubai UAE. Co-Infected . Adults. Jayaweera. DT, . Campa. A, . Casillas. VJ, Martinez SS, Shin DH, Li Y, Young S, Baum MK. Background. P. atients co-infected with HIV/HCV compared. . to those infected with. . Vaughan Somerville. Who am I. Heel Prick. Sweat Test. Heel Prick. Diagnosis. Effects 1 in 2500 people. ~ 450 people in NZ. Average life expectancy 37-40. 97% of males are in fertile. What is Cystic Fibrosis (CF). DR.SHERIN.A.KHALAM,MSc. (PSY),MDS,FICOI. Associate Professor, PMS College of Dental Science & Research, Kerala University of Health . Sciences;. Consultant Maxillofacial Surgeon & Surgical Head, SUT. John Scott, MD, MSc. Associate Professor, University of Washington. Associate Clinic Director, . Hep. /Liver Clinic, Harborview. Presentation prepared by: . John Scott, MD, MSc; Sanjeev Arora, MD; Paula Cox-North, PhD. Broadening Your Health Care Team . Meredith Wiltsie, MN, ANP, FNP . Nurse Practitioner, adult Cystic Fibrosis program. Cystic Fibrosis Education Day. March 11. th. , 2017. No disclosures. If you are a CF Center patient, why do you need a Primary Care Physician? . and Why. SESSION LEADERS: . JOAO ALBERTO M. DE ANDRADE, MD . JOYCE LEE, MD. What is pulmonary fibrosis and. why is it a problem?. JOYCE S. LEE, MD. PULMONARY FIBROSIS: WHAT AND WHY. NOVEMBER 13, 2015. Masi. . Khaja. , M.D. Objectives . Epidemiology. Natural History. Clinical Presentation. Pathogenesis. Approach to Diagnosis. Treatment. What is NAFLD?. Nonalcoholic Fatty Liver Disease. [NAFLD]. STEATOSIS. What is a Strategic Roadmap?. Execution. Resources. Tactics. Metrics. Strategy. Markets . Offerings. Positioning. Insights. Customers. Company. Competitors. . The . Growth® . Gears Process. Long-Term . Due to liver damage and healing. Progresses through 4 stages, ending in cirrhosis. Liver cirrhosis causes more than . 1 million deaths per year. http://depts.washington.edu/hepstudy/definitions/uploads/49/Liver_Cirrhosis.png. Kidney/Renal Fibrosis Treatment Market Report published by value market research, it provides a comprehensive market analysis which includes market size, share, value, growth, trends during forecast period 2019-2025 along with strategic development of the key player with their market share. Further, the market has been bifurcated into sub-segments with regional and country market with in-depth analysis. View More @ https://www.valuemarketresearch.com/report/kidney-renal-fibrosis-treatment-market Hepatologist. East & North Hertfordshire NHS Trust. Royal Free London NHS Foundation Trust. ELF Research Group. University College London. Liver disease. Scale of the problem. Liver disease is the 5. A. . Ansari. Deptt. . Of Pathology. JNMC,AMU. Fatty liver. Gross Description. Fatty liver is caused by the excessive deposition of fats, especially triglycerides, in the cells of the liver.. The liver appears enlarged and pale/yellowish in . Best of ILC 2018. About these slides. These slides provide highlights of new data presented at the International Liver Congress 2018. Please feel free to use, adapt, and share these slides for your own personal use; however, please acknowledge EASL as the source. Download PDF The Fatty Liver Solution™ eBook by Duncan Capicchiano - A natural and effective approach to tackling fatty liver disease.

Download Document

Here is the link to download the presentation.
"New Insights into the Roadmap of Pathogenesis of Liver Fibrosis"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.